Tender Details

Country: Poland
Summary: Delivery of Drugs Used in Drug Programs Zp/55/23
PLT Ref No: 93032915
Deadline: 08 Jan 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: PLN 4304141.7
Notice Type: Tender
Document Ref. No.: 730858-2023
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
A detailed description is included in attachment no. 2.1-2.14 product and price specification
Laronidasum - for the drug program - treatment of Hurler B.24 disease
Alglucosidasum alfa - drug used in the drug program - treatment of Pompe disease B.22
Interferonum beta-1a for the drug program - Treatment of sclerosisdisseminated B.29
Toxinum botulinicum type A - for the drug program - treatment of spasticity in cerebral palsy B.30
Immunoglobulins used as part of the drug programs B.17 and B.67
Tobramycinum for the drug program - treatment of chronic lung infections in beneficiaries with cystic fibrosisose B.27
Triptorelinum for the drug program - treatment of precocious puberty in children B.18
Infliximabum for the drug program - treatment of Crohn's disease B.32
Dimethylis fumaras - for the drug program - treatment of multiple sclerosis B.29
Adalimumab for drug program- treatment of Crohn's disease B.32
Immunoglobulins used in the drug program - treatment of primary immunodeficiencies in children B.17
Natalizumab - for the drug program - treatment of multiple sclerosis B.29
Drugs used as part of the drug program B.112 - Treatment cystic fibrosis
Immunoglobulins - used in drug programs - treatment of primary immunodeficiencies in children B.17
Doc Title: Delivery of drugs used in drug programs ZP/55/23
Contract Type: supplies
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Delivery of Drugs Used in Drug Programs Zp/55/23 - Poland Tender

The UPPER SILESIAN CHILDREN'S HEALTH CENTER SAINT JOHN PAWEŁ II INDEPENDENT PUBLIC CLINICAL HOSPITAL NO. 6 OF THE MEDICAL UNIVERSITY OF SILESIA IN KATOWICE, a Government sector organization in Poland, has announced a new tender for Delivery of Drugs Used in Drug Programs Zp/55/23. This tender is published on PolandTenders under PLT Ref No: 93032915 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-01-08.

The estimated tender value is PLN 4304141.7, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.